Mark Rus Email & Phone Number
@shire.com
1 phone found area 781
LinkedIn matched
Who is Mark Rus? Overview
A concise factual answer block for searchers comparing this professional profile.
Mark Rus is listed as Chief Executive Officer & Director at Delix Therapeutics at Delix Therapeutics, based in Concord, Massachusetts, United States. AeroLeads shows a work email signal at shire.com, phone signal with area code 781, and a matched LinkedIn profile for Mark Rus.
Mark Rus previously worked as Chief Executive Officer & Director at Delix Therapeutics and EIR; Chief Executive Officer & Board Director (CNS/Neuropsychiatry Start-Up) at Atlas Venture. Mark Rus holds Master Of Science (Ms), International Economics from The London School Of Economics And Political Science (Lse).
Email format at Delix Therapeutics
This section adds company-level context without repeating Mark Rus's masked contact details.
AeroLeads found 1 current-domain work email signal for Mark Rus. Compare company email patterns before reaching out.
About Mark Rus
Globally proven strategic, operational, and commercial executive + Board Director with experience across therapeutic areas and global markets. CEO experience leading VC-backed start-up/Series A stage, through to $10M-+$2.5B in P&L, and teams between <10 to >600 people within and across North America, Europe and Japan. Enjoys orchestrating talent and teams towards ambitious objectives, driven by curiosity. Experience working in lean, ambiguous, and fast-paced business contexts. Investor, fundraising, and clinical stage experience. Additional talent/business development, public policy, electoral campaign(s), and communications experiences. Dual Canadian/EU citizen and US greencard holder.
Listed skills include Strategy, Pharmaceutical Industry, Cross Functional Team Leadership, Strategic Planning, and 20 others.
Mark Rus's current company
Company context helps verify the profile and gives searchers a useful next step.
Mark Rus work experience
A career timeline built from the work history available for this profile.
Eir; Chief Executive Officer & Board Director (Cns/Neuropsychiatry Start-Up)
Group Vice President - Neuroscience
P&L responsibility+leadership for +600 team, +$2.5BN revenue, and Shire's US Neuroscience commercial execution and strategy. Strong focus on commercial talent development across Shire. Vyvanse BED and Mydayis PIII + Launch Strategy/Execution; Global lifecycle + Business Development Strategy, across long/mid/short-term. Additional Neuroscience pipeline.
Vice President - Portfolio Strategy Team Lead - International Neuroscience
Led team of direct and indirect reports towards execution of Shire's ex-US Neuroscience commercial launch/strategy/new market development efforts, with P&L responsibility for 20+ markets and transition to #1 ranked growth within Shire. Co-Chaired Shire-Shionogi Alliance for Japan, as well as internal BD/lifecycle/global cross-functional/and commercial.
Business Unit Director - Shire Canada
Lead sales, marketing, product launch, business development, people-development, and related commercial strategy/lifecycle development/operations in Canada for Shire's Neuroscience Business Unit.
Regional Director
Led teams of sales representatives to #1 ranking regional sales performance and product launch nationally across US in a multi-product range and timelines, while mentoring several individuals for personal and career development.
European Projects Manager
Led cross-functional and cross-border projects and strategy development for Shire International leadership team. Projects included: Product launch planning; business development; European pricing and reimbursement strategy; performance management; financial analysis and reporting; and policy briefings.
Press Secretary And Policy Advisor
Press Secretary, speechwriter, and policy advisor to Canadian Minister of State - John Godfrey.
Policy Advisor
Policy Advisor in Canadian Privy Council Office, secretariat of the federal Canadian cabinet, providing non-partisan advice and support to the Prime Minister and leadership, coordination, and support to federal departments and agencies of government.
Mark Rus education
Master Of Science (Ms), International Economics
Corporate Governance - Effectiveness And Accountability In The Boardroom
Bachelor Of Arts (Ba), Political Science & International Comparitive Studies
Frequently asked questions about Mark Rus
Quick answers generated from the profile data available on this page.
What company does Mark Rus work for?
Mark Rus works for Delix Therapeutics.
What is Mark Rus's role at Delix Therapeutics?
Mark Rus is listed as Chief Executive Officer & Director at Delix Therapeutics at Delix Therapeutics.
What is Mark Rus's email address?
AeroLeads has found 1 work email signal at @shire.com for Mark Rus at Delix Therapeutics.
What is Mark Rus's phone number?
AeroLeads has found 1 phone signal(s) with area code 781 for Mark Rus at Delix Therapeutics.
Where is Mark Rus based?
Mark Rus is based in Concord, Massachusetts, United States while working with Delix Therapeutics.
What companies has Mark Rus worked for?
Mark Rus has worked for Delix Therapeutics, Atlas Venture, Shire, Shire Pharmaceuticals, and Parliament Of Canada.
How can I contact Mark Rus?
You can use AeroLeads to view verified contact signals for Mark Rus at Delix Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Mark Rus attend?
Mark Rus holds Master Of Science (Ms), International Economics from The London School Of Economics And Political Science (Lse).
What skills is Mark Rus known for?
Mark Rus is listed with skills including Strategy, Pharmaceutical Industry, Cross Functional Team Leadership, Strategic Planning, Product Launch, Market Analysis, Change Management, and Marketing Strategy.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial